“Omalizumab In The Treatment Of Refractory Urticarial Vasculitis Triggered By SARS-Cov-2 Infection: A Pediatric Case Report”. Dermatology Practical & Conceptual, vol. 14, no. 4, Oct. 2024, p. e2024252, https://doi.org/10.5826/dpc.1404a252.